---
title: "Dune Acquisition Corp II - Unit | 10-K: FY2025 Revenue: USD 0"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279093365.md"
datetime: "2026-03-13T21:09:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279093365.md)
  - [en](https://longbridge.com/en/news/279093365.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279093365.md)
generator: "portal-rs"
---

# Dune Acquisition Corp II - Unit | 10-K: FY2025 Revenue: USD 0

Revenue: As of FY2025, the actual value is USD 0.

EPS: As of FY2025, the actual value is USD 0.22.

EBIT: As of FY2025, the actual value is USD -4.253 M.

#### Overview

Dune Acquisition Corp. II is a blank check company that has not generated any operating revenues to date and does not expect to until after completing a Business Combination. 

#### Net Income (Loss)

-   For the year ended December 31, 2025, the company reported a net income of $3,349,485, which includes $3,801,400 in interest earned on marketable securities offset by $451,915 in formation and general and administrative costs.
-   For the period from September 13, 2024 (inception) through December 31, 2024, the company recorded a net loss of - $36,702.

#### Loss from Operations

-   Loss from operations was - $451,915 for the year ended December 31, 2025.
-   Loss from operations was - $36,702 for the period from September 13, 2024 (inception) through December 31, 2024.

#### Interest Income

-   Interest earned on marketable securities held in the Trust Account was $3,801,400 for the year ended December 31, 2025.
-   No interest income was reported for the period from September 13, 2024 (inception) through December 31, 2024.

#### Formation and General and Administrative Costs

-   These costs amounted to $451,915 for the year ended December 31, 2025.
-   These costs were $36,702 for the period from September 13, 2024 (inception) through December 31, 2024.

#### Cash Flow from Operating Activities

-   Cash used in operating activities was - $429,113 for the year ended December 31, 2025.
-   Cash used in operating activities was - $30,472 for the period from September 13, 2024 (inception) through December 31, 2024.

#### Cash Flow from Investing Activities

-   Net cash used in investing activities was - $144,109,375 for the year ended December 31, 2025, primarily for investment in the Trust Account.
-   No cash flow from investing activities was reported for the period from September 13, 2024 (inception) through December 31, 2024.

#### Cash Flow from Financing Activities

-   Net cash provided by financing activities was $144,890,421 for the year ended December 31, 2025.
-   Net cash provided by financing activities was $44,290 for the period from September 13, 2024 (inception) through December 31, 2024.

#### Key Financial Position Metrics (as of December 31, 2025)

-   Marketable securities held in the Trust Account totaled $147,910,775.
-   Cash balance was $365,751.
-   Working capital surplus was $289,539.
-   The deferred underwriting fee payable was $5,750,000.
-   The per-share redemption value for Public Shares was approximately $10.29.

#### Outlook / Guidance

Dune Acquisition Corp. II anticipates incurring significant costs for acquisitions and will not generate operating revenues until a Business Combination is completed. The company targets completing its initial Business Combination by August 8, 2026, utilizing funds from the Trust Account and additional working capital. Management plans to address substantial doubt regarding its going concern ability through this Business Combination.

### Related Stocks

- [IPODU.US](https://longbridge.com/en/quote/IPODU.US.md)
- [CCAQU.US](https://longbridge.com/en/quote/CCAQU.US.md)

## Related News & Research

- [C21 Investments deregisters common shares under Exchange Act Section 12(g)](https://longbridge.com/en/news/297085290.md)
- [NetBrands files to deregister common stock under Exchange Act Section 12(g)](https://longbridge.com/en/news/297030615.md)
- [14:12 ETEstuary Rewrites Its Runtime for Agents at Enterprise Scale](https://longbridge.com/en/news/297077080.md)
- [12:16 ETPVOLVE Coming Soon to Coral Gables With New Studio Opening](https://longbridge.com/en/news/296939239.md)
- [BRAIN Biotech cuts FY 2025/26 BRAINBiocatalysts outlook, sees revenue growth below FY 2024/25 level](https://longbridge.com/en/news/297129636.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**